Page last updated: 2024-11-03

ag 1879 and Nasopharyngeal Carcinoma

ag 1879 has been researched along with Nasopharyngeal Carcinoma in 1 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ho, HC1
Huang, CC1
Lu, YT1
Yeh, CM1
Ho, YT1
Yang, SF1
Hsin, CH1
Lin, CW1

Other Studies

1 other study available for ag 1879 and Nasopharyngeal Carcinoma

ArticleYear
Epigallocatechin-3-gallate inhibits migration of human nasopharyngeal carcinoma cells by repressing MMP-2 expression.
    Journal of cellular physiology, 2019, Volume: 234, Issue:11

    Topics: Catechin; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; MAP Kinase Signaling System; Matri

2019